The recently published report on the Global Liquid Biopsy Market Analysis, Share, Size, Growth, Trends and Report 2023 by MarkNtel Advisors provides valuable insights into the changing dynamics of the market. The report comprehensively examines the factors driving growth, as well as the challenges, restraints, opportunities, trends, and developments influencing the industry.
The primary objective of this report is to enlighten stakeholders about the market’s fluctuations, equipping them with the necessary information to make informed decisions regarding strategic investments and future participation. The study incorporates data from historical years (2018-2021), using 2022 as the base year, and offers a detailed industry outlook during the forecast period (2023-2028).
Request for Free Sample Report: Liquid Biopsy Market Report Sample 2023-28
“In case you missed it, we are currently revising our reports. Click on the “request sample report” button to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”
To present a comprehensive overview of the industry, the analysts at MarkNtel Advisors provide unbiased, accurate, and reliable insights. The Liquid Biopsy Market is projected to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28. Their research findings are presented using graphs, tables, and explanations to facilitate a better understanding of the market.
The investigation covers various aspects, including market attractiveness, key players and their strategies, the most and least lucrative segments, as well as growth environment and demand analysis across different regions. To gain a deeper understanding of the factors influencing the industry’s growth trajectory, the researchers employ tools such as Porter’s Five Forces Model.
Read Full Report: Liquid Biopsy Market Report
Segmentation Analysis
The report highlights the highly fragmented nature of the Liquid Biopsy Market, examining the factors influencing the growth or decline of each segment. It provides detailed and accurate data on the actual size and volume of the market across different geographical locations.
-By Work Process
- Sample Preparation
- Library Preparation
- Sequencing
- Data Analysis
-By Technology
- PCR
- NGS
- FISH
- Other Technologies
-By Usage
- RUO
- Clinical
-By Sample Type
- Blood
- Urine
- Saliva
- Cerebrospinal Fluid
-By Products
- Test /Services
- Kits and Consumables
- Instruments
-By Circulating Biomarkers
- Circulating Tumor Cells
- Cell-free DNA
- Circulating Cell-Free RNA
- Exosomes and Extracellular Vesicles
- Others
-By Disease Type
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Melanoma
- Other Cancers
- Non-Oncology Disorders
-By Clinical Application
- Treatment Monitoring
- Prognosis and Recurrence Monitoring
- Treatment Selection
- Diagnosis and Screening
The Liquid Biopsy Market spans various geographical including:
-By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific
Impact of Covid-19 on Liquid Biopsy Market
The Covid-19 pandemic in 2020 had a profound impact on the Liquid Biopsy Market. This section of the report delves into the changing landscape of the industry amidst regulatory shifts during the crisis. It provides insights into key parameters such as changes in purchase patterns and demand rates among end-users across different geographies, influencing market growth. Additionally, the section highlights the challenges faced by leading players in meeting customer demand with limited resources, as well as their strategies to sustain business operations during the pandemic. The data presented in this section is based on rigorous interactions with industry experts to capture the ground reality and monitor the rapidly changing dynamics.
Competitive Landscape
The research study offers an unbiased and straightforward investigation of the leading players operating in the Liquid Biopsy Market. It includes comprehensive company profiling, covering aspects such as business strategy, overview, and financial performance. Furthermore, the analysts highlight the key product/service offerings, performance indicators, recent developments, and geographic presence of the following leading companies in the industry:
- Bio-Rad Laboratories
- Biocept Inc
- Abcodia Ltd
- Chronix Biomedical
- Epic Sciences Inc
- Hoffmann-La Roche AG
- Cynvenio Biosystems, Inc.
- GUARDANT HEALTH, INC
- Illumina, Inc.
- NeoGenomics Laboratories, Inc.
- Menarini Silicon Biosystems, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific
- Personal Genome Diagnostics, Inc.
- Qiagen N.V.
ABOUT US:
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.
Media Representative
Company Name: MarkNtel Advisor
Email: mailto:[email protected] Email
Phone: +1 628 895 8081 +91 120 4268433,
Address: 5214F Diamond Heights Blvd #3092,
San Francisco, CA 94131
United States
About Author
